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B7H3 ameliorates LPS-induced 
acute lung injury via attenuation 
of neutrophil migration and 
infiltration
Yan Li1,*, Jie Huang2,*, Niamh M. Foley3, Yunyun Xu1, Yi Ping Li1, Jian Pan1, H. Paul Redmond3, 
Jiang Huai Wang3 & Jian Wang4
Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are characterized by an 
excessive inflammatory response within the lungs and severely impaired gas exchange resulting from 
alveolar-capillary barrier disruption and pulmonary edema. The costimulatory protein B7H3 functions 
as both a costimulator and coinhibitor to regulate the adaptive and innate immune response, thus 
participating in the development of microbial sepsis and pneumococcal meningitis. However, it is 
unclear whether B7H3 exerts a beneficial or detrimental role during ALI. In the present study we 
examined the impact of B7H3 on pulmonary inflammatory response, polymorphonuclear neutrophil 
(PMN) influx, and lung tissue damage in a murine model of lipopolysaccharide (LPS)-induced direct 
ALI. Treatment with B7H3 protected mice against LPS-induced ALI, with significantly attenuated 
pulmonary PMN infiltration, decreased lung myeloperoxidase (MPO) activity, reduced bronchoalveolar 
lavage fluid (BALF) protein content, and ameliorated lung pathological changes. In addition, B7H3 
significantly diminished LPS-stimulated PMN chemoattractant CXCL2 production by inhibiting NF-κB 
p65 phosphorylation, and substantially attenuated LPS-induced PMN chemotaxis and transendothelial 
migration by down-regulating CXCR2 and Mac-1 expression. These results demonstrate that B7H3 
substantially ameliorates LPS-induced ALI and this protection afforded by B7H3 is predominantly 
associated with its inhibitory effect on pulmonary PMN migration and infiltration.
Acute lung injury (ALI) and its more severe condition acute respiratory distress syndrome (ARDS) were first 
described in 19671 and are characterized by an excessive inflammatory response within the lungs and severely 
impaired gas exchange resulting from alveolar-capillary barrier disruption and pulmonary edema2–4. Clinically, 
patients with ALI/ARDS present with acute onset, progressive hypoxemia, bilateral lung infiltrates on chest radi-
ographs, increased work of breathing, and noncardiogenic respiratory failure2–4. ALI/ARDS is a common clinical 
disorder and presents substantial health problems worldwide. It has been estimated that ALI/ARDS affects one in 
10 general intensive care unit patients, with 200,000 cases annually in the United States2–4,5. Although improved 
survival rates of ALI/ARDS have been observed during the past two decades, largely owing to advances in sup-
portive critical care medicine6,7, mortality rates of ALI/ARDS remain high, ranging from 25% to 45% depending 
on various factors such as comorbidities2–4,5. Currently, there are no pharmacological approaches available for the 
treatment of ALI/ARDS, which highlights the urgent need in the development of therapeutic strategies for ALI/
ARDS.
The B7 superfamily of costimulatory proteins plays an important role in the regulation of Ag-specific T 
cell-mediated immune responses8,9. B7H3, a newly discovered member of the B7 superfamily, has been identified 
in both humans and mice by sharing ∼ 88% amino acid sequence identity10,11. Accumulated evidence supports the 
notion that B7H3 possesses a contrasting role in regulating T cell-mediated immune responses by functioning as 
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both a T cell costimulator and coinhibitor11–14. More recently, it has been shown that B7H3 is also involved in the 
innate immunity-associated inflammatory response. Although B7H3 is not expressed in significant amounts on 
freshly isolated human lymphocytes, it is induced in human monocytes/macrophages and dendritic cells upon 
inflammatory cytokine stimulation11–13,15. A soluble form of B7H3 (sB7H3), released from monocytes, dendritic 
cells, and activated T cells, is detectable in the circulation of healthy humans16. Our recent clinical studies found 
that patients diagnosed with sepsis17 and bacterial meningitis18 displayed significantly elevated levels of plasma 
and cerebrospinal fluid (CSF) sB7H3, and moreover, levels of sB7H3 in the circulation and CSF correlated closely 
with the disease status and clinical outcome in these patients17,18. In experimental LPS-induced septic shock17 
and pneumococcal meningitis19, we further demonstrated that B7H3 augmented the TLR4 agonist lipopoly-
saccharide (LPS)- and gram-positive Streptococcus pneumoniae (S. pneumoniae)-stimulated proinflammatory 
cytokine production via both a TLR4- and TLR2-dependent manner. These results suggest that B7H3 functions 
as a costimulator of the innate immunity by augmenting the inflammatory response, and thus, may contribute to 
the development of microbial sepsis and pneumococcal meningitis.
In this study, we examined the influence of B7H3 on pulmonary inflammatory response, leukocyte influx, and 
lung edema in a murine model of LPS inhalation-induced direct ALI. Unexpectedly, we found that administra-
tion of B7H3 markedly attenuated LPS-induced lung injury, with significant reductions in pulmonary polymor-
phonuclear neutrophil (PMN) infiltration, lung myeloperoxidase (MPO) activity, and bronchoalveolar lavage 
fluid (BALF) protein content. In addition, treatment with B7H3 substantially inhibited LPS-stimulated over-
expression and release of chemokine CXCL2 in the lungs. Furthermore, B7H3 in vitro significantly diminished 
LPS-stimulated murine alveolar macrophage (MAMφ ) CXCL2 production by inhibiting nuclear factor-kappaB 
(NF-κ B) p65 phosphorylation and strongly attenuated LPS-induced PMN chemotaxis and transendothelial 
migration by down-regulating CXCR2 and Mac-1 expression.
Results
B7H3 attenuates PMN infiltration in the lungs and ameliorates lung tissue damage during LPS-
induced ALI. Significantly enhanced influx of leukocytes (p < 0.05) (Fig. 1A) and PMNs (p < 0.01) (Fig. 1B) 
into the lungs was observed in mice at 24 hrs after receiving an intranasal instillation of LPS compared with 
mice received an intranasal instillation of phosphate-buffered saline (PBS). MPO activity in lung tissues was 
also significantly increased in LPS-treated mice (p < 0.01 versus PBS-treated mice) (Fig. 1C). Administration of 
B7H3 at 2 hrs after LPS inhalation substantially attenuated LPS-induced leukocyte and PMN infiltration in the 
lungs by 75% and 79%, respectively, as well as lung MPO activity (p < 0.05, p < 0.01 versus LPS-treated mice) 
Figure 1. B7H3 attenuates LPS-induced PMN infiltration and lung tissue damage. Male Balb/c mice 
were randomized into PBS, B7H3, LPS, and LPS+ B7H3 groups (n = 12 per group). BALF leukocyte (A) and 
PMN (B) counts, lung MPO activity (C), and BALF protein concentrations (D) were assessed 24 hrs after LPS 
inhalation as described in the Methods. Intranasal instillation of LPS (20 μ g/mouse) resulted in significantly 
increased BALF leukocyte numbers, PMN counts, and protein concentrations as well as lung MPO activity, 
which were markedly attenuated by B7H3 treatment. Data are mean ± SD. * p < 0.05, * * p < 0.01 versus PBS 
group; ≠p < 0.05, ≠≠p < 0.01 versus LPS group.
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(Fig. 1A–C). Furthermore, LPS inhalation resulted in lung edema as evidenced by significantly elevated protein 
levels in BALF (p < 0.05 versus PBS-treated mice), which was markedly attenuated by B7H3 treatment (p < 0.05 
versus LPS-treated mice) (Fig. 1D). Notably, B7H3 itself affected neither PMN influx nor BALF protein levels 
(Fig. 1). Histological examination of the lung tissues showed substantial morphological alterations including 
edema, haemorrhage, alveolar collapse, and PMN infiltration in LPS-treated mice, whereas treatment with B7H3 
markedly ameliorated these pathological changes (Fig. 2).
B7H3 down-regulates CXCL2, but not TNF-α, IL-1β, and IL-6, expression and release during 
LPS-induced ALI. Following LPS inhalation, there were significant increases in proinflammatory cytokines 
TNF-α , IL-1β , IL-6 and chemokine CXCL2 at both mRNA (Fig. 3A) and protein (Fig. 3B) levels in the lungs 
(p < 0.05, p < 0.01 versus PBS-treated mice). Moreover, LPS inhalation resulted in substantially increases 
of TNF-α , IL-6, and CXCL2 levels in BALF (p < 0.05, p < 0.01 versus PBS-treated mice) (Fig. 3C). Treatment 
with B7H3 markedly attenuated LPS-stimulated CXCL2 expression in the lungs and release into the BALF 
(p < 0.01 versus LPS-treated mice) (Fig. 3). Although B7H3 significantly attenuated LPS-stimulated TNF-α and 
IL-6 mRNA expression (p < 0.05, p < 0.01 versus LPS-treated mice) (Fig. 3A), it had no inhibitory effects on 
LPS-stimulated TNF-α and IL-6 protein expression and release (Fig. 3B,C).
B7H3 does not affect PMN apoptosis, but diminishes LPS-stimulated PMN ROS generation. 
There were no statistically significant differences found in apoptotic rates of PMNs collected from BALF among 
PBS-treated, B7H3-treated, LPS-treated, and LPS + B7H3-treated mice (Fig. 4A). Moreover, although in vitro LPS 
stimulation led to a significant delay in PMN spontaneous apoptosis after incubation of PMNs with LPS for 12 
and 24 hrs (p < 0.05, p < 0.01 versus PMNs incubated with PBS), the addition of B7H3 did not show any modula-
tory effects on LPS-delayed PMN spontaneous apoptosis (Fig. 4B).
Next, we examined the influence of B7H3 on PMN reactive oxygen species (ROS) production, as represented 
by superoxide anion generation in LPS-stimulated PMNs. As shown in Fig. 4C, stimulation of PMNs with LPS 
resulted in a substantial increase in superoxide anion generation; however, the addition of B7H3 significantly 
attenuated LPS-stimulated ROS production (p < 0.05, p < 0.01 versus LPS-stimulated PMNs). In contrast, B7H3 
had no inhibitory effects on PMA-stimulated PMN superoxide anion generation (Fig. 4D).
Figure 2. B7H3 ameliorates LPS-induced lung pathological alterations. Male Balb/c mice were randomized 
into PBS, B7H3, LPS, and LPS+ B7H3 groups (n = 12 per group). Lung histological changes were assessed 
24 hrs after LPS inhalation as described in the Methods. Representative images of haematoxylin and eosin 
stained sections of lung tissues for PBS (A), B7H3 (B), LPS (C), and LPS+ B7H3 (D) are shown, indicating that 
treatment with B7H3 strongly ameliorates LPS-induced lung edema, haemorrhage, alveolar collapse, and PMN 
infiltration.
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B7H3 attenuates LPS-induced PMN chemotaxis and transendothelial migration via 
down-regulation of CXCR2 and Mac-1 expression. We first examined the ability of PMN chemot-
axis toward the chemoattractant CXCL2. LPS stimulation resulted in significantly enhanced PMN chemotaxis 
(p < 0.01 versus PBS-treated PMNs) (Fig. 5A), which correlated with LPS-induced up-regulation of CXCR2 
expression on PMNs (p < 0.01 versus PBS-treated PMNs) (Fig. 5B,C). However, the LPS-induced increase in 
PMN chemotaxis was strongly attenuated by B7H3 at both 1.0 and 5.0 μ g/ml concentrations (p < 0.05 versus 
LPS-stimulated PMNs) (Fig. 5A), and moreover, the LPS-induced up-regulation of PMN CXCR2 expression was 
also substantially inhibited by B7H3 (p < 0.05 versus LPS-stimulated PMNs) (Fig. 5B,C).
We further assessed PMN migration across the murine pulmonary endothelial cell (MPEC) monolayer in 
response to the chemoattractant fMLP. As shown in Fig. 5D, stimulation of PMNs with LPS significantly enhanced 
their transendothelial migration (p < 0.01 versus PBS-treated PMNs), with more PMN migration toward the 
chemoattractant fMLP than toward culture medium. Moreover, LPS stimulation markedly up-regulated surface 
expression of Mac-1 on PMNs (p < 0.01 versus PBS-treated PMNs) (Fig. 5E,F). Notably, the addition of B7H3 
substantially attenuated LPS-stimulated PMN transendothelial migration (p < 0.05 versus LPS-treated PMNs) 
(Fig. 5D) and Mac-1 expression (p < 0.05 versus LPS-treated PMNs) (Fig. 5E,F).
Figure 3. B7-H3 down-regulates LPS-stimulated CXCL2, but not TNF-α, IL-1β, and IL-6, expression and 
release. Male Balb/c mice were randomized into PBS, B7H3, LPS, and LPS+ B7H3 groups (n = 12 per group). 
Lung mRNA (A) and protein (B) expression and BALF levels (C) of TNF-α , IL-1β , IL-6, and CXCL2 were 
measured 24 hrs after LPS inhalation as described in the Methods. Remarkably, treatment with B7H3 down-
regulated LPS-stimulated chemokine CXCL2 expression in the lung and attenuated its release into the BALF. 
Data are mean ± SD. * p < 0.05, * * p < 0.01 versus PBS group; ≠p < 0.05, ≠≠p < 0.01 versus LPS group.
www.nature.com/scientificreports/
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B7H3 inhibits LPS-stimulated MAMφ CXCL2 expression through attenuation of NF-κB p65 
phosphorylation. As shown in Fig. 6A,B, there were significant increases in CXCL2 expression at both 
mRNA and protein levels observed in LPS-stimulated MAMφ s at different time points after LPS stimulation 
(p < 0.01 versus PBS-treated MAMφ s). This up-regulated expression of CXCL2 correlated with LPS-induced 
phosphorylation of NF-κ B p65 and MARK p38 (p < 0.01 versus PBS-treated MAMφ s) (Fig. 6C,D). Incubation 
of MAMφ s with B7H3 significantly attenuated LPS-stimulated CXCL2 mRNA expression (Fig. 6A) and protein 
production (Fig. 6B) (p < 0.05 versus LPS-treated MAMφ s), and inhibited LPS-induced activation of NF-κ B p65, 
but not MARK p38 (p < 0.05 versus LPS-treated MAMφ s) (Fig. 6C,D). B7H3 itself did not affect the expression 
of CXCL2 and phosphorylation of NF-κ B p65 and MARK p38 (Fig. 6).
Discussion
B7H3, a newly discovered member of the B7 superfamily of costimulatory proteins, possesses a contrasting role in 
regulating the adaptive immune response by functioning as both a T cell costimulator and coinhibitor11–14. More 
recently, it has been shown that B7H3 also participates in the innate immune response by acting as a costimulator 
of innate immunity to augment inflammatory responses during experimental septic shock and pneumococcal 
meningitis17,19. In the current study, we investigated the impact of B7H3 on pulmonary inflammatory response, 
PMN influx into the lungs, and lung tissue damage in a murine model of LPS-induced direct ALI. We reported 
that B7H3 effectively protected mice against LPS-induced lung injury, with significantly attenuated pulmonary 
PMN infiltration, decreased lung MPO activity, reduced BALF protein content, and ameliorated lung patho-
logical changes. We further demonstrated that B7H3 significantly inhibited LPS-stimulated overexpression and 
release of PMN chemoattractant CXCL2 through attenuation of NF-κ B p65 activation, and substantially attenu-
ated LPS-induced PMN chemotaxis and transendothelial migration via down-regulation of CXCR2 and Mac-1 
expression.
Exuberant infiltration and accumulation of leukocytes, in particular PMNs in both interstitial and alveolar 
spaces of the lungs is one of the most important pathological hallmarks of ALI2,20,21. Although a quick and appro-
priate influx of PMNs from the circulation into the lungs is essential for clearance of microbial pathogens and 
debris from the alveolar space, excessive and persistent sequestration of PMNs may cause additional injury to 
the lungs by release of several toxic mediators including ROS, proteases, proinflammatory cytokines, and pro-
coagulant molecules, thus exacerbating ALI20,22,23. It has been reported that the number of PMNs in the BALF of 
patients with ARDS correlates closely with the severity and poor outcome of disease20,24, while depletion of PMNs 
Figure 4. The effect of B7-H3 on PMN apoptosis and ROS production. (A,B) PMN apoptosis in BALF 
collected 24 hrs after LPS inhalation (n = 12 per group) or PMN apoptosis in vitro at indicated time points 
after PMNs treated with PBS, B7H3, LPS, and LPS+ B7H3 (n = 8 per group) were assessed as described in the 
Methods. Data are mean ± SD. (C,D) ROS production was determined after PMNs treated with LPS and LPS+ 
B7H3 or PMA and PMA+ B7H3 as described in the Methods. B7H3 had no effect on PMN apoptosis both  
in vitro and in vivo, but significantly diminished LPS-induced ROS generation in PMNs. Data are mean ± SD of 
seven to eight independent experiments and each experiment was conducted in duplicate. * p < 0.05, * * p < 0.01 
versus PBS group; ≠p < 0.05, ≠≠p < 0.01 versus LPS group.
www.nature.com/scientificreports/
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in animal models of LPS-induced ALI ameliorates lung injury with reduced endothelial-epithelial damage and 
capillary-alveolar permeability25,26. In the present study, an intranasal instillation of LPS in mice led to mark-
edly enhanced PMN infiltration and MPO activity in the lungs, accompanied by lung edema and tissue damage. 
Treatment with B7H3 significantly attenuated LPS-induced influx of PMNs into the lungs, thus ameliorating lung 
edema and injury.
We next examined the underlying mechanism(s) by which B7H3 attenuates LPS-induced PMN infiltration 
and accumulation in the lungs. It has been shown that PMN recruitment from the circulation into the site of 
inflammation depends predominantly on the chemokine receptor CXCR2, and reduced CXCR2 expression on 
circulating PMNs is associated with diminished PMN influx into the infectious site27,28. We found that B7H3 
treatment significantly inhibited LPS-stimulated up-regulation of CXCR2 expression on PMNs, thus attenuat-
ing LPS-induced PMN chemotaxis toward the chemoattractant CXCL2. We further demonstrated that B7H3 
down-regulated LPS-induced overexpression of Mac-1, a critical adhesion molecule responsible for PMN 
extravasation via transendothelial migration29, and consequently, attenuated PMN transmigration across the 
MPEC monolayer. The chemoattractant CXCL2 plays a key role in PMN recruitment, and BALF obtained from 
Figure 5. B7H3 attenuates LPS-induced PMN chemotaxis and transendothelial migration by down-
regulating CXCR2 and Mac-1 expression. PMN chemotaxis toward CXCL2 (A) and migration across the 
MPEC monolayer (D) were assessed as described in the Methods. Surface expression of CXCR2 (B,C) and 
Mac-1 (E,F) on PMNs was detected by FACScan analysis. The addition of B7H3 significantly attenuated LPS-
induced PMN chemotaxis and transendothelial migration toward the chemoattractants CXCL2 and fMLP, 
which are closely associated with the inhibitory effect of B7H3 on LPS-induced up-regulation of CXCR2 and 
Mac-1 expression. Data are mean ± SD of six to eight independent experiments and each experiment was 
conducted in duplicate. * p < 0.05, * * p < 0.01 versus PBS group; ≠p < 0.05 versus LPS group.
www.nature.com/scientificreports/
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patients with ARDS has been shown to be highly chemotactic for human PMNs27,30. We found that LPS inhalation 
resulted in markedly increased CXCL2 expression in the lungs and elevated CXCL2 concentrations in the BALF, 
whereas B7H3 treatment significantly reduced LPS-stimulated CXCL2 production and release into the BALF. 
Delayed spontaneous apoptosis of PMNs sequestrated in the lungs and subsequently released toxic mediators 
including ROS by these PMNs have been shown to contribute to the development and progression of ALI and/
or ARDS20,31. We found that B7H3 treatment did not affect apoptotic rates of PMNs in the BALF or LPS-induced 
delay in PMN spontaneous apoptosis; however, it substantially reduced LPS-stimulated PMN ROS production.
Our previous work has revealed that B7H3, in addition to regulating T cell-mediated immune responses, acts 
as a costimulator of innate immunity by augmenting proinflammatory cytokine and chemokine production in 
monocytes/macrophages and microglial cells17,19. In this study, we further examined the influence of B7H3 on 
pulmonary inflammatory response in a murine model of LPS-induced direct ALI. LPS inhalation led to markedly 
increased expression and production of proinflammatory cytokines TNF-α , IL-1β , IL-6, and chemokine CXCL2 
in the lungs. Surprisingly, B7H3 strongly attenuated LPS-stimulated CXCL2 expression at both mRNA and pro-
tein levels as well as its release into the BALF. We then analyzed the effect of B7H3 on NF-κ B p65 and MARK p38 
activation in LPS-stimulated MAMφ s. B7H3 substantially inhibited LPS-induced NF-κ B p65 phosphorylation, 
thereby attenuating CXCL2 expression and production in LPS-stimulated MAMφ s. Notably, B7H3 also signifi-
cantly attenuated LPS-stimulated TNF-α and IL-6 mRNA expression in the lungs, although it had no inhibitory 
effect on TNF-α and IL-6 protein expression.
It has been well documented that B7H3, being both a T cell costimulator and coinhibitor, plays a contrast-
ing role in regulation of T cell-mediated immune responses11–14, indicating its involvement in autoimmun-
ity and self tolerance32. In addition to the adaptive immunity, B7-H3 has been shown to promote the innate 
immunity-associated inflammatory response by augmenting proinflammatory cytokine and chemokine produc-
tion in monocytes/macrophages and microglial cells17,19, thus participating in the development of experimental 
sepsis and pneumococcal meningitis. The accumulated evidence has revealed that elevated levels of B7H3 in 
certain human tumours correlate closely with poor clinical outcome including survival, prognosis, and tumour 
grade33,34; however, B7H3 also possesses strong antitumour effects34,35, suggesting the dual functions B7H3 has 
in tumour immunity. Interestingly, we demonstrated an inhibitory action of B7H3 on PMNs in the present study, 
which is largely in contrast to the previously observed stimulatory effect of B7H3 on monocytes/macrophages and 
microglial cells17,19. These somewhat discordant results indicate that B7H3 acts as not only a costimulator but also 
Figure 6. B7H3 inhibits LPS-stimulated MAMφ CXCL2 expression by attenuating NF-κB p65 
phosphorylation. MAMφ s were incubated with PBS, B7H3, LPS, and LPS+ B7H3 for various time periods. 
CXCL2 mRNA (A) and protein (B) expression was assessed as described in the Methods. Intracellular 
expression of phophorylated NF-κ B p65 (C) and MAPK p38 (D) was detected by FACScan analysis. B7H3 
strongly down-regulated LPS-stimulated CXCL2 expression in MAMφ s at both mRNA and protein levels, 
and this correlates with the attenuation of LPS-induced phosphorylation of NF-κ B p65, but not MAPK p38, 
by B7H3. Data are mean ± SD of six to eight independent experiments and each experiment was conducted in 
duplicate. * * p < 0.01 versus PBS group; ≠p < 0.05, ≠≠p < 0.01 versus LPS group.
www.nature.com/scientificreports/
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a coinhibitor during the innate immunity-initiated inflammatory response, which might be due to the existence 
of two receptors for B7H3 with opposing functions32, probably dependent on the targeted innate effector cells.
Taken together, in the current study we demonstrate that B7H3 strongly attenuates PMN infiltration and 
sequestration in the lungs, thus protecting mice against LPS-induced ALI. We have further revealed that B7H3 
significantly diminishes LPS-stimulated PMN chemoattractant CXCL2 production by inhibiting NF-κ B p65 
phosphorylation and substantially reduces LPS-induced PMN chemotaxis and transendothelial migration by 
down-regulating CXCR2 and Mac-1 expression, which could be the two underlying mechanisms responsible for 
B7H3-attenuated pulmonary PMN infiltration and accumulation.
Methods
Regents and mAbs. LPS (E. coli serotype O55B5), fibronectin, PMA, fMLP, and recombinant mouse B7H3 
were purchased from Sigma-Aldrich (St. Louis, MO, USA) and R&D Systems (Minneapolis, MN, USA), respec-
tively. PE-conjugated anti-phospho p65 and anti-phospho p38 MAPK mAbs were obtained from Cell Signaling 
Technology (Beverly, MA, USA). PE- or FITC-conjugated anti-CXCR2 and anti-Mac-1 mAbs were purchased 
form R&D systems and BD Bioscience (San Jose, CA, USA), respectively. Endothelial cell basal medium-2 (EBM-
2) MV and endothelial growth medium-2 (EGM-2) were obtained from PromoCell (Heidelberg, Germany), and 
other culture medium and reagents used for cell cultures were purchased from Invitrogen Life Technologies 
(Paisley, Scotland, U.K.). All other chemicals, unless indicated, were from Sigma-Aldrich.
Mice and LPS-induced ALI. Pyrogen-free, 8- to 10-week old male Balb/c mice were purchased from Slac 
(Shanghai, China). Mice were housed in barrier cages under controlled environmental conditions (12/12 h of 
light/dark cycle, 55% ± 5% humidity, 23 °C) in the Institute of Paediatric Research, Soochow University and had 
free access to standard laboratory chow and water. All animal studies were approved by the institutional animal 
care and use committee at Soochow University and complied with the animal welfare act. The methods applied in 
this study were carried out in accordance with the approved guidelines.
Age- and weight-matched male Balb/c mice (n = 48) were anesthetized by intramuscular injection of keta-
mine/xylazine (80/10 mg/kg) admixture and randomized into one of the following 4 study groups: PBS, B7H3, 
LPS, and LPS + B7H3 (n = 12 per group). ALI was induced by intranasal instillation of LPS (20 μ g/mouse in 
100 μ l PBS) as described previously36. Mice in PBS and B7H3 groups received intranasal instillation of PBS and 
B7H3 (5 μ g/mouse), respectively, while mice in LPS + B7H3 group received B7H3 at 2 hrs after LPS inhalation. 
The experiment was terminated at 24 hrs after LPS inhalation, and lung tissues and BALF were harvested and 
collected thereafter. The in vivo study was carried out in two separate experiments.
Measurement of leukocyte influx and protein content in BALF. BALF was collected after the lungs 
were lavaged with 1 ml PBS for three times as described previously37. Total and differential leukocyte counts 
in BALF were carried out using a standard haemocytometer and Wright-Giemsa staining of cytospin prepara-
tions, respectively. Total protein concentrations in BALF were determined using a BCA protein assay kit (Piece, 
Rockford, IL, USA).
Assessment of MPO activity. MPO activity in the lungs was assessed as described previously38. Briefly, 
lung tissues were collected and homogenized in KPO4 buffer containing 0.5% hexa-decyl-trimethyl-ammonium 
bromide. After centrifugation, the resultant supernatant was diluted in reaction solution containing o-dianisidine 
hydrochloride and hydrogen peroxide. Changes in optical density (OD) were measured at 460 nm to calculate 
MPO activity.
Lung histological examination. The harvested lung tissues were fixed in 4% paraformaldehyde, embed-
ded in paraffin, cut into 4-μ m sections, and stained with haematoxylin and eosin. Morphological changes in lung 
tissues were evaluated by light microscopy in a blinded fashion.
Measurement of inflammatory cytokines and chemokine. TNF-α , IL-1β , IL-6, and CXCL2 mRNA 
expression in the lungs and MAMφ s were assessed by quantitative real-time RT-PCR as described previously19. 
Briefly, Total RNA was extracted from lung tissues and MAMφ s using a GeneEluteTM mammalian total RNA 
purification kit (Sigma-Aldrich) and reverse-transcribed into cDNA using the SuperScript first-strand synthe-
sis system (Invitrogen). Amplification of cDNA was conducted using a LightCycler system (Roche Molecular 
Biochemicals, Indianapolis, IN, USA). The target gene mRNA expression was normalized with the housekeeping 
gene β -actin. The gene-specific primers used in this study were listed in Table 1. Concentrations of TNF-α , IL-1β , 
IL-6, and CXCL2 in BALF, lung tissues, and MAMφ supernatants were quantitatively measured by ELISA (eBio-
science, San Diego, CA, USA) according to the manufacturer’s instructions.
Product 
length (bp) Sense Antisense
Mouse TNF-α 122 CTGAACTTCGGGGTGATCGG GGCTTGTCACTCGAATTTTGAGA
Mouse IL-1β 116 GAAATGCCACCTTTTGACAGTG TGGATGCTCTCATCAGGACAG
Mouse IL-6 131 CTGCAAGAGACTTCCATCCAG AGTGGTATAGACAGGTCTGTTGG
Mouse CXCL2 108 CCAACCACCAGGCTACAGG GCGTCACACTCAAGCTCTG
β -actin 211 GTGACGTTGACATCCGTAAAGACC ATCTGCTGGAAGGTGGACAGTGAG
Table 1.  Gene-specific PCR primers.
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Isolation and culture of primary murine PECs, AMφ, and PMNs. MPECs were isolated using the 
microbead technique as described previously39. Briefly, harvested lungs from adult Balb/c mice were minced, 
digested, and filtered through a 100-μ m nylon mesh. The resultant cell suspension was incubated with the 
anti-mouse CD31 Ab (BD Biosciences) and anti-rat IgG-coated micromagnetic beads (MACS Miltenyl 
Biotec Ltd., Surrey, U.K.). Cells captured were cultured with EBM-2 containing EGM-2 MV and 20% FCS in 
fibronectin-coated flasks at 37oC, 5% CO2 conditions. This procedure yielded the MPEC monolayer with > 90% 
homogeneity. MPECs from first to third passage were used for experiments. MAMφ s were obtained from BALF 
as described previously40. Briefly, the lungs of adult Balb/c mice were lavaged three times with 1 ml PBS con-
taining 2 mM EDTA. The collected BALF was centrifuged, and the resultant cell pellet was resuspended and 
incubated with DMEM containing 10% FCS in 24-well plates for 60 min to remove the non-adherent cells. This 
procedure yielded MAMφ s with > 95% purity. PMNs were isolated from the bone marrow of adult Balb/c mice by 
discontinuous Percoll gradient centrifugation as described previously41.
Assays for PMN apoptosis and ROS production. Apoptotic rates of PMNs collected from BALF and 
PMNs incubated with PBS, B7H3 (1.0 μ g/ml), LPS (100 μ g/ml), and LPS + B7H3 (100 + 1.0 μ g/ml) for various 
time periods were assessed using an Annexin V apoptosis detection kit (eBioscence).
PMN ROS production was assessed with the fluorogenic substrate lucigenin (bis-N-methylacridinium 
nitrate) (Sigma-Aldrich) as described previously42. Briefly, murine PMNs were incubated with LPS (100 μ g/ml) 
or LPS + B7H3 (100 + 1.0 μ g/ml) for 60 min. PMNs were also incubated with PMA (1.0 μ g/ml) to measure the 
maximal receptor-independent ROS production.
Assessment of PMN chemotaxis and transendothelial migration. PMN chemotaxis was assessed as 
described previously43. Briefly, murine PMNs were incubated with PBS, B7H3 (1.0 and 5.0 μ g/ml), LPS (100 μ g/ml), 
and LPS + B7H3 (100 μ g/ml + 1.0 and 5.0 μ g/ml) for 60 min, plated onto 48-well chemotaxis plates (NeuroProbe, 
Gaithersburg, MD, USA), and allowed to migrate toward culture medium or CXCL2 (30 ng/ml) (R&D Systems) 
for 60 min.
PMN transendothelial migration was assessed as described previously44. Briefly, MPECs were grown to form 
the monolayer on fibronectin-coated Transwell inserts (3.0-μ m-diameter pores) (BD Biosciences). Murine PMNs 
preincubated with PBS, B7H3, LPS, and LPS + B7H3 for 60 min were added into the upper chamber, and fMLP 
(10−8 M) was added into the lower chamber. After PMNs were allowed to migrate for 3 hrs, non-migrated PMNs 
(upper chamber) and migrated PMNs (lower chamber) were collected and counted.
FACScan analysis for CXCR2 and Mac-1 expression. Murine PMNs were incubated with PBS, B7H3 
(1.0 and 5.0 μ g/ml), LPS (100 μ g/ml), and LPS + B7H3 (100 μ g/ml + 1.0 and 5.0 μ g/ml) for 60 min, and stained 
with anti-CXCR2 and anti-Mac-1 mAbs conjugated with PE or FITC. PE- or FITC-conjugated isotype-matched 
mAbs were used as the control. FACScan analysis was performed from at least 10,000 events for detecting the 
surface expression of CXCR2 and Mac-1 on PMNs.
Assays for NF-κB p65 and MAPK p38 phosphorylation. Primary MAMφ s were incubated with PBS, 
B7H3 (1.0 μ g/ml), LPS (100 μ g/ml), and LPS + B7H3 (100 + 1.0 μ g/ml) for various time periods. Cells were fixed 
and permeabilised with Phosflow fix buffer and Phosflow perm buffer (BD Biosciences) for 30 min on ice. Cells 
were then stained with PE-conjugated anti-phospho p65 and anti-phospho p38 MAPK mAbs. PE-conjugated 
isotype-matched mAbs were used as the control. FACScan analysis was performed from at least 10,000 events for 
detecting the fold change of intracellular phosphorylated p65 or phosphorylated p38 expression.
Statistical analysis. All data are presented as the mean ± SD. Statistical analysis was performed with 
GraphPad software version 5.01 (Prism, La Jolla, CA, USA). Comparison between groups was carried out using 
one-way ANOVA, followed by Bonferroni correction when necessary, and Mann-Whitney U test, where appro-
priate. Differences were judged to be statistically significant when the p value was less than 0.05.
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